Earnings History Data for Amarin Corporation plc (AMRN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amarin Corporation plc

Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-02-2024	PM		AMRN	Amarin Corporation plc	494.03	-0.01	-0.05	0.00	Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61M [2/29/2024 7:04 AM]	1.07	-0.25 (-19.05%)	1.20	-0.12 (-9.09%)	0.65 - 2.13	7,961,043	1,360,000	541,487
Amarin Q4 2023 Earnings Preview [2/28/2024 10:44 AM] Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61M [2/29/2024 7:04 AM]
01-11-2023	PM		AMRN	Amarin Corporation plc	279.46	-0.05	-0.05	-0.01	Amarin GAAP EPS of -$0.05, revenue of $66M [11/1/2023 7:08 AM]	0.6877	-0.01 (-1.21%)	0.70	0.0 (-0.14%)	0.65 - 2.23	2,848,786	1,620,000	102,646
Amarin Q3 2023 Earnings Preview [10/31/2023 12:06 PM] Amarin GAAP EPS of -$0.05, revenue of $66M [11/1/2023 7:08 AM]
03-05-2023	PM	7:00 AM ET (May 3)	AMRN	Amarin Corporation plc	560.44	-0.04	-0.03	-0.08	Amarin Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $85.7M beats by $4.47M [5/3/2023 7:02 AM]	1.35	-0.06 (-4.35%)	1.45	0.04 (2.84%)	1.04 - 2.76	4,651,819	2,530,000	19,467
Amarin Non-GAAP EPS of $0.02 beats by $0.03, revenue of $85.97M beats by $4.74M [5/3/2023 7:02 AM] Amarin posts 9% decline in Q1 2023 topline amid generic competition [5/3/2023 9:24 AM]
01-03-2023	PM	7:00 AM ET (Mar 1)	AMRN	Amarin Corporation plc	734.97	N/A	-0.01	0.04	Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M [3/1/2023 7:01 AM]	2.06	0.03 (1.23%)	1.99	-0.04 (-1.97%)	1.04 - 3.74	4,556,244	4,180,000	132,900
Amarin Q4 2022 Earnings Preview [2/28/2023 12:54 PM] Amarin 8% higher after Sarissa wins proxy battle with management [2/28/2023 12:13 PM] Amarin inks licensing deal with CSL for heart drug Vazkepa in Australia, New Zealand [2/28/2023 9:35 AM] Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M [3/1/2023 7:01 AM]
27-10-2022	PM	7:00 AM ET (Oct 27)	AMRN	Amarin Corporation plc	463.69	-0.01	-0.06	0.01	Amarin reports Q3 mixed earnings; continues to suspend 2022 revenue guidance [10/27/2022 7:04 AM]	1.16	-0.02 (-2.12%)	1.22	0.04 (3.39%)	1.04 - 4.89	3,352,533	2,260,000	75,468
Amarin Q3 2022 Earnings Preview [10/26/2022 3:10 PM] Amarin reports Q3 mixed earnings; continues to suspend 2022 revenue guidance [10/27/2022 7:04 AM] Amarin posts Q3 beat, continues to suspend 2022 revenue guidance [10/27/2022 11:28 AM] Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update [Oct-27-22 07:00AM]
03-08-2022	PM	7:00 AM ET (Aug 3)	AMRN	Amarin Corporation plc	508.17	-0.18	-0.07	0.02	Amarin Non-GAAP EPS of -$0.09 misses by $0.03, revenue of $94.4M beats by $6.19M [8/3/2022 7:02 AM]	1.26	-0.07 (-5.26%)	1.33	0.0 (0.00%)	1.11 - 5.97	4,484,299	2,560,000	272,416
Amarin Q2 2022 Earnings Preview [8/2/2022 11:58 AM] Amarin Non-GAAP EPS of -$0.09 misses by $0.03, revenue of $94.4M beats by $6.19M [8/3/2022 7:02 AM]
04-05-2022	PM	6:00 AM ET (May 4)	AMRN	Amarin	1,067	-0.08	-0.02	0.00	Amarin Non-GAAP EPS of -$0.06 misses by $0.05, revenue of $94.6M misses by $33.61M [5/4/2022 7:04 AM]	1.56	-1.17 (-42.88%)	1.90	-0.84 (-30.66%)	1.45 - 5.97	35,573,988	2,810,000	1,954,493
Amarin Q1 2022 Earnings Preview [5/3/2022 2:01 PM] Amarin Non-GAAP EPS of -$0.06 misses by $0.05, revenue of $94.6M misses by $33.61M [5/4/2022 7:04 AM] Amarin down 23% following earnings misses and suspending revenue guidance [5/4/2022 9:06 AM] New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack) [May-03-22 08:00AM] Amarin Reports First Quarter 2022 Financial Results and Provides Business Update [May-04-22 07:00AM] Why Amarin Stock Is Sinking on Wednesday [May-04-22 10:51AM]
01-03-2022	PM	6:00 AM ET (Mar 1)	AMRN	Amarin Corporation plc	1,290	0.04	-0.01	0.01	Amarin Non-GAAP EPS of $0.06 beats by $0.09, revenue of $144.49M beats by $2.32M [3/1/2022 6:02 AM]	3.17	-0.14 (-4.23%)	3.32	0.01 (0.30%)	2.79 - 7.30	2,519,116	2,060,000	22,193
Amarin Q4 2021 Earnings Preview [2/28/2022 2:15 PM] Amarin Non-GAAP EPS of $0.06 beats by $0.09, revenue of $144.49M beats by $2.32M [3/1/2022 6:02 AM] Amarin stock rises after Q4 earnings beat amid Vascepa generic competition [3/1/2022 7:42 AM] Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-01-22 06:00AM] Amarin (AMRN) Q4 2021 Earnings Call Transcript [Mar-01-22 01:00PM]
03-11-2021	PM	6:00 AM ET (Nov 3)	AMRN	Amarin Corporation plc	1,910	0.01	-0.03	-0.02	Amarin EPS beats by $0.01, misses on revenue [11/3/2021 6:03 AM]	4.26	-0.56 (-11.72%)	4.51	-0.31 (-6.43%)	3.83 - 9.25	9,621,550	3,010,000	164,924
Amarin Q3 2021 Earnings Preview [11/2/2021 11:36 AM] Amarin EPS beats by $0.01, misses on revenue [11/3/2021 6:03 AM] Amarin shares fall after Q3 topline miss, cash position update [11/3/2021 6:40 AM] Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against D-Market, Gaotu, Amarin, and BioMarin and Encourages Investors to Contact the Firm [Nov-02-21 09:00PM] SHAREHOLDER ALERT: BMRN AMRN HMLP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Nov-03-21 05:40AM] Amarin Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-03-21 06:00AM] AMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Amarin Corporation plc Investors of Class Action and Lead Plaintiff Deadline: December 20, 2021 [Nov-03-21 11:00AM] CLASS ACTION UPDATE for AMRN, RECAF and CEI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Nov-03-21 12:00PM] Amarin (AMRN) Q3 Earnings Top, Vascepa Sales Decline Y/Y [Nov-03-21 11:17AM] Amarin (AMRN) Q3 2021 Earnings Call Transcript [Nov-03-21 01:01PM] SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm [Nov-03-21 02:11PM] LAWSUITS FILED AGAINST BMRN, AMRN and CEI - Jakubowitz Law Pursues Shareholders Claims [Nov-03-21 02:45PM]
05-08-2021	PM	6:10 AM ET (Aug 5)	AMRN	Amarin Corporation plc	1,630	0.02	-0.04	0.01	Amarin EPS beats by $0.06, beats on revenue [8/5/2021 6:03 AM]	4.84	0.41 (9.12%)	4.53	0.09 (2.03%)	3.36 - 9.25	9,647,736	3,180,000	98,043
Amarin Q2 2021 Earnings Preview [8/4/2021 1:25 PM] Amarin EPS beats by $0.06, beats on revenue [8/5/2021 6:03 AM] Amarin posts Q2 earnings beat, provides cash position update [8/5/2021 7:58 AM] Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update [Aug-05-21 06:00AM] Amarin (AMRN) Q2 2021 Earnings Call Transcript [Aug-05-21 12:00PM] Why Amarin Is Soaring Today [Aug-05-21 02:34PM]
29-04-2021	PM	5:55 AM ET (Apr 29)	AMRN	Amarin Corporation plc	2,020	N/A	-0.05	-0.06	Amarin EPS beats by $0.07, misses on revenue [4/29/2021 6:16 AM]	5.24	0.05 (0.96%)	5.24	0.0 (0.00%)	3.36 - 9.25	6,228,084	4,540,000	3,027
Amarin Q1 2021 Earnings Preview [4/28/2021 1:06 PM] Amarin EPS beats by $0.07, misses on revenue [4/29/2021 6:16 AM] Amarin reports decline in Q1 revenue ahead of European launch of VAZKEPA [4/29/2021 7:31 AM] Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel [Apr-29-21 06:00AM] Amarin Reports First Quarter 2021 Financial Results and Provides Business Update [Apr-29-21 06:10AM] Amarin (AMRN) Q1 Earnings Top, Vascepa Sales Hit by COVID-19 [Apr-29-21 12:00PM] Amarin (AMRN) Q1 2021 Earnings Call Transcript [Apr-29-21 08:01PM]
25-02-2021	PM	6:00 AM ET (Feb 25)	AMRN	Amarin Corporation plc	2,950	0.01	-0.01	0.02	Amarin EPS beats by $0.04, beats on revenue [2/25/2021 5:58 AM]	6.96	-0.34 (-4.66%)	7.47	0.17 (2.33%)	3.36 - 18.00	5,324,970	5,722,029	152,859
Amarin EPS beats by $0.04, beats on revenue [2/25/2021 5:58 AM] Amarin Q4 2020 Earnings Preview [2/24/2021 11:55 AM] Amarin Q4 results led by strong Vascepa sales [2/25/2021 9:48 AM] How Amarin Beat Wall Street's Q4 Estimates [Feb-25-21 11:21AM]
05-11-2020	PM	6:00 AM ET (Nov 5)	AMRN	Amarin Corporation plc	1,950	-0.02	0.01	-0.01	Amarin EPS in-line, beats on revenue [11/5/2020 6:01 AM]	4.51	-0.48 (-9.62%)	4.58	0.07 (1.55%)	3.36 - 26.12	10,625,317	3,207,379	4,250

04-08-2020	PM	5:00 AM ET (Aug 4)	AMRN	Amarin Corporation plc	2,500	0.01	-0.08	-0.01	Amarin EPS beats by $0.11, misses on revenue [8/4/2020 6:03 AM]	7.02	0.25 (3.69%)	6.53	-0.24 (-3.54%)	3.95 - 26.12	9,824,056	5,489,381	310,256